Providing you the best range of minoxidil and finasteride topical solution, morr f minoxidil and finasteride lipid solution, finasteride 1mg tablet, finpecia 1mg tablet, minoxidil and finasteride solution and capmatinib tablets 200 mg with effective & timely delivery.
Minoxytop F Solution is a medicine used to treat common hereditary hair loss in men. It prevents further hair loss and helps hair to regrow. It increases blood flow to the hair follicles on your scalp, which prevents hair cell death and also enhances new hair growth.
It is most effective for baldness or thinning at the top of the scalp but less effective at the front or for receding hairline. Benefits are less likely if you have been bald for many years or have a large area of hair loss. Morr F 10% Solution is not suitable for sudden or unexplained hair loss
Finasteride 1 mg is indicated for treatment of the first stage of the hair loss (androgenetic alopecia) in males. Finasteride 1 mg stabilizes the process of the androgenetic alopecia in the 18-41 year old males.
Finpecia Tablet is a medicine used to treat common hereditary hair loss. It prevents further hair loss and helps hair to regrow. It stops the production of a hormone that causes excessive hair fall or baldness and also increases hair growth.
Finasteride stops DHT being produced and this helps shrink your prostate and reduce hair loss. You may notice an improvement a little while after you start taking finasteride. However, for an enlarged prostate it can take up to 6 months for this medicine to take full effect.
Request Callback
Yes! I am interested
Minoxidil And Finasteride Solution
Ask For Price
Product Price :Get Latest Price Product Brochure
Product Details:
Minoxidil Strength
10%
Finasteride Strength
0.1%
Pack Size
60 ml
Brand
Actihair-10 F
Form
Spray
Usage Area
Frontal Scalp
Gender
Male
Prescription
Prescription
Actihair-10 F Solution is a prescription topical medication used for the treatment of androgenetic alopecia (male pattern baldness) in men. It is a dual-action formula that is not indicated for use by women.It is primarily used to address common hereditary or premature hair loss and hair thinning in men.
Capmatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA approved test.
